DexCom (DXCM)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Key Insights
Share Price
$72.92Market Cap
$29.22 BillionTotal Outstanding Shares
400.73 Million SharesTotal Employees
9,600Dividend
No dividendIPO Date
April 14, 2005SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.dexcom.com
Historical Stock Splits
If you bought 1 share of DXCM before June 13, 2022, you'd have 4 shares today.
| Execution Date | Split Amount |
|---|---|
| June 13, 2022 | 4-for-1 |
Cash Flow Statement
July 1, 2023 to June 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $891.40 Million |
| Net Cash Flow From Investing Activities, Continuing | $121.30 Million |
| Net Cash Flow From Investing Activities | $121.30 Million |
| Net Cash Flow, Continuing | $-253.30 Million |
| Net Cash Flow From Operating Activities | $891.40 Million |
| Net Cash Flow From Financing Activities | $-1.27 Billion |
| Net Cash Flow | $-255.50 Million |
| Exchange Gains/Losses | $-2.20 Million |
| Net Cash Flow From Financing Activities, Continuing | $-1.27 Billion |
Income Statement
July 1, 2023 to June 30, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $3.13 Billion |
| Selling, General, and Administrative Expenses | $1.25 Billion |
| Research and Development | $545.00 Million |
| Basic Earnings Per Share | $1.70 |
| Income Tax Expense/Benefit, Deferred | $-60.00 Million |
| Cost Of Revenue | $1.47 Billion |
| Income/Loss From Continuing Operations After Tax | $666.90 Million |
| Gross Profit | $2.47 Billion |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss | $666.90 Million |
| Basic Average Shares | $780.70 Million |
| Diluted Earnings Per Share | $1.61 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Revenues | $3.93 Billion |
| Income Tax Expense/Benefit | $140.00 Million |
| Costs And Expenses | $3.13 Billion |
| Diluted Average Shares | $840.90 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $666.90 Million |
| Net Income/Loss Attributable To Parent | $666.90 Million |
| Operating Expenses | $1.79 Billion |
| Operating Income/Loss | $681.50 Million |
| Income/Loss From Continuing Operations Before Tax | $806.90 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Balance Sheet
July 1, 2023 to June 30, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $1.95 Billion |
| Intangible Assets | $114.50 Million |
| Inventory | $570.30 Million |
| Current Liabilities | $1.72 Billion |
| Current Assets | $4.85 Billion |
| Liabilities And Equity | $6.80 Billion |
| Other Non-current Assets | $1.84 Billion |
| Assets | $6.80 Billion |
| Noncurrent Liabilities | $2.64 Billion |
| Wages | $116.10 Million |
| Prepaid Expenses | $69.30 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.43 Billion |
| Equity | $2.43 Billion |
| Other Current Liabilities | $1.61 Billion |
| Other Current Assets | $4.21 Billion |
| Liabilities | $4.36 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ2024 Financhle. All Rights Reserved.